Win Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Win Advisors's AMGN Position: Q2 2025 in Review
Win Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 3,241 shares — an estimated $1.01M sold.
Win Advisors first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $1.01M in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Win Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Win Advisors sold 3,241 Amgen shares in Q2 2025, an estimated $1.01M.
- Win Advisors first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
- Win Advisors's Amgen position peaked at $1.01M in Q1 2025.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Win Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.